Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Serreen F. Meki
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Trump Moves to Delay Medicare Drug Pricing—A Win for Big Pharma

Apr 16, 2025 | Medicare and Medicaid

Donald Trump signed an executive order on Tuesday directing the Department of Health and Human Services to work with Congress on amending a key component of Medicare’s new drug price negotiation authority. The directive specifically targets a timeline that drugmakers...

Department of Justice Files False Claims Act Lawsuit Against Wound Care Provider

Apr 14, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On April 4, 2025, the Department of Justice announced that it had filed a lawsuit under the federal False Claims Act against Vohra Wound Physicians Management and its founder, Dr. Ameet Vohra.  According to the DOJ, Dr. Vohra and his company allegedly submitted false...

MEDICARE’S “WITHOUT FAULT” PROVISION: A PROVIDER’S SECRET WEAPON?

Mar 24, 2025 | Administrative Law, Health Care, Medicare and Medicaid, Overpayment Appeals

Because Medicare processes over one billion fee-for-service claims annually, it is impossible for CMS and its contractors to review every claim – or even a substantial percentage of claims – on a pre-payment basis.  Accordingly, Medicare has set up various...

Dr. Oz Faces Scrutiny During Senate Confirmation Hearing for CMS Administrator

Mar 18, 2025 | Healthcare Transactions, Medicare and Medicaid

On March 14, Dr. Mehmet Oz, President Donald Trump’s nominee for the Centers for Medicare and Medicaid Services (CMS) Administrator, appeared before the Senate Finance Committee for his confirmation hearing. During the two-and-a-half-hour session, Dr. Oz navigated a...

Spectra Clinical Labs Operator Convicted for Role in Defrauding Medicare of Over $4 Million

Mar 4, 2025 | Medicare and Medicaid

A federal jury in Detroit convicted Sherif Khalil, a 50-year-old man from Redondo Beach, California, for his involvement in a fraud scheme that put Medicare out of over $4 million. The fraud stemmed from the submission of false claims for medically unnecessary urine...

Opt-in DME Leads and Medicare’s Anti-Solicitation Rule

Feb 20, 2025 | DMEPOS, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

If you are a DMEPOS supplier and are purchasing opt-in Medicare leads, you should be aware of Medicare’s prohibition against telephone solicitation of beneficiaries. In order to enroll as a Medicare DMEPOS supplier, and as a condition of payment, DMEPOS providers must...
« Older Entries

Recent Posts

  • DOJ Criminal Chief Issues Sweeping Memo Regarding White Collar Criminal Enforcement
  • Pharmaceutical Manufacturer Agrees to Pay $3.6M to Resolve False Claims Act Investigation
  • Are the False Claims Act’s Qui Tam Provisions Constitutional? Another Court Weighs In
  • Popular Restaurant Chain Pays $7.8 Million to Resolve Pandemic-Related False Claims Act Case
  • Robotics/AI Company Agrees to Seven-Figure False Claims Act Settlement

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group